Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BioLineRx - 14 Year Stock Price History | BLRX

Historical daily share price chart and data for BioLineRx since 2011 adjusted for splits and dividends. The latest closing stock price for BioLineRx as of June 13, 2025 is 4.69.
  • The all-time high BioLineRx stock closing price was 3354.00 on July 25, 2011.
  • The BioLineRx 52-week high stock price is 35.60, which is 659.1% above the current share price.
  • The BioLineRx 52-week low stock price is 2.30, which is 51% below the current share price.
  • The average BioLineRx stock price for the last 52 weeks is 13.37.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
BioLineRx Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.8079 10.2240 10.9520 2.4300 4.6900 -45.21%
2024 29.5721 61.2000 62.2000 7.8080 8.5600 -86.37%
2023 52.7734 26.0000 98.0000 22.5120 62.8000 166.10%
2022 52.9454 83.2000 87.2000 22.6480 23.6000 -71.08%
2021 115.1000 98.0000 195.2000 79.2000 81.6000 -19.05%
2020 77.6543 93.6000 144.8000 44.4000 100.8000 12.00%
2019 187.9434 300.0000 440.4600 78.8000 90.0000 -65.70%
2018 543.2278 660.0000 870.0000 260.9400 262.3800 -59.88%
2017 609.2000 562.7400 783.0000 487.8000 654.0000 18.48%
2016 584.6662 780.0000 780.0000 450.0000 552.0000 -29.23%
2015 1089.1427 1026.0000 1704.0000 738.0010 780.0000 -19.75%
2014 1204.3703 1740.0000 1842.0000 738.0010 972.0000 -42.35%
2013 1465.2072 1590.0000 2850.0000 948.0010 1686.0000 11.07%
2012 1697.3059 1893.6000 3330.0000 1338.0000 1518.0000 -20.19%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.020B $0.029B
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.271B 31.99
Zoetis (ZTS) United States $73.161B 27.30
Takeda Pharmaceutical (TAK) Japan $48.365B 9.62
Daiichi Sankyo, - (DSNKY) Japan $46.601B 23.88
BeOne Medicines - (ONC) Cayman Islands $29.540B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.150B 0.00
Merck (MKKGY) Germany $17.047B 12.49
Summit Therapeutics (SMMT) United States $14.690B 0.00
Shionogi (SGIOY) Japan $14.547B 0.00
United Therapeutics (UTHR) United States $12.781B 11.31
Neurocrine Biosciences (NBIX) United States $12.310B 42.17
Orion OYJ (ORINY) Finland $10.212B 27.62
IPSEN (IPSEY) France $10.004B 0.00
Corcept Therapeutics (CORT) United States $7.429B 60.40
Stevanato Group S.p.A (STVN) Italy $7.111B 43.48
Madrigal Pharmaceuticals (MDGL) United States $6.563B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ionis Pharmaceuticals (IONS) United States $5.664B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $3.989B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.975B 0.00
Hypermarcas (HYPMY) Brazil $2.939B 19.33
Catalyst Pharmaceuticals (CPRX) United States $2.870B 10.06
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.429B 13.14
NewAmsterdam Pharma (NAMS) Netherlands $2.269B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.170B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.000B 0.00
Indivior (INDV) United States $1.915B 8.12
Centessa Pharmaceuticals (CNTA) United Kingdom $1.653B 0.00
Dyne Therapeutics (DYN) United States $1.638B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.512B 0.00
Ocular Therapeutix (OCUL) United States $1.391B 0.00
Guardian Pharmacy Services (GRDN) United States $1.246B 0.00
Harrow (HROW) United States $1.112B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.105B 22.11
Enliven Therapeutics (ELVN) United States $1.075B 0.00
Collegium Pharmaceutical (COLL) United States $0.938B 5.06
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.926B 0.00
Ardelyx (ARDX) United States $0.861B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Elite Pharmaceuticals (ELTP) United States $0.718B 0.00
Xeris Biopharma Holdings (XERS) United States $0.680B 0.00
Xencor (XNCR) United States $0.654B 0.00
KalVista Pharmaceuticals (KALV) United States $0.644B 0.00
AleAnna (ANNA) United States $0.592B 0.00
Regulus Therapeutics (RGLS) United States $0.561B 0.00
Altimmune (ALT) United States $0.561B 0.00
Relay Therapeutics (RLAY) United States $0.552B 0.00
USANA Health Sciences (USNA) United States $0.550B 11.96
Verve Therapeutics (VERV) United States $0.549B 0.00
Bioventus (BVS) United States $0.544B 13.79
Theravance Biopharma (TBPH) United States $0.535B 0.00
Tourmaline Bio (TRML) United States $0.505B 0.00
Zevra Therapeutics (ZVRA) United States $0.499B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
Oruka Therapeutics (ORKA) United States $0.470B 0.00
Siga Technologies (SIGA) United States $0.454B 9.49
Organogenesis (ORGO) United States $0.389B 0.00
Savara (SVRA) United States $0.382B 0.00
Liminatus Pharma (LIMN) United States $0.375B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.367B 9.91
Aquestive Therapeutics (AQST) United States $0.340B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.44
Nanobiotix S.A (NBTX) France $0.252B 0.00
ProKidney (PROK) United States $0.245B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.235B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
MediWound (MDWD) Israel $0.221B 0.00
OmniAb (OABI) United States $0.217B 0.00
4D Molecular Therapeutics (FDMT) United States $0.203B 0.00
Profound Medical (PROF) Canada $0.197B 0.00
Larimar Therapeutics (LRMR) United States $0.184B 0.00
Aldeyra Therapeutics (ALDX) United States $0.167B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Journey Medical (DERM) United States $0.158B 0.00
Avita Medical (RCEL) United States $0.146B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Achieve Life Sciences (ACHV) Canada $0.113B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Nektar Therapeutics (NKTR) United States $0.107B 0.00
Champions Oncology (CSBR) United States $0.106B 17.41
Fractyl Health (GUTS) United States $0.101B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.100B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Wellgistics Health (WGRX) United States $0.096B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
Surrozen (SRZN) United States $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 58.22
Inotiv (NOTV) United States $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
ESSA Pharma (EPIX) Canada $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.054B 0.00
Metagenomi (MGX) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Klotho Neurosciences (KLTO) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
FibroGen (FGEN) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00